News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Opexa Therapeutics (OPXA) Reports First Quarter 2013 Financial Results and Provides Corporate Update


5/14/2013 7:38:05 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Opexa Therapeutics, Inc. (NASDAQ: OPXA), a leader in developing a patient specific T-cell immunotherapy for multiple sclerosis (MS), today reported financial results for the quarter ended March 31, 2013 and provided an overview of recent corporate developments.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES